Federated Hermes
FENC icon

Federated Hermes’s Fennec Pharmaceuticals FENC Stock Holding History

Federated Hermes’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,401
Closed -$14.8K – 2087
2026
Q1 		$14.8K Sell
2,401
-515
-18% -$3.98K ﹤0.01% 1813
2025
Q4 		$22.5K Hold
2,916
– – ﹤0.01% 1749
2025
Q3 		$27.3K Buy
2,916
+2,127
+270% +$18.4K ﹤0.01% 1767
2025
Q2 		$6.55K Buy
+789
New +$5.4K ﹤0.01% 1865
2020
Q3 		– Sell
-166
Closed -$1K – 2274
2020
Q2 		$1K Sell
166
-205
-55% -$1.52K ﹤0.01% 2144
2020
Q1 		$2K Buy
+371
New +$2.42K ﹤0.01% 2012

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Federated Hermes's FENC Position: Q2 2026 in Review

Federated Hermes sold out of Fennec Pharmaceuticals (FENC) in Q2 2026, closing a stake of 2,401 shares — an estimated $14.8K sold.

Federated Hermes first reported a position in FENC in Q1 2020 and held it in 6 quarters. The position peaked at $27.3K in Q3 2025. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Federated Hermes reported no remaining Fennec Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 2,401 Fennec Pharmaceuticals shares in Q2 2026, an estimated $14.8K.
  • Federated Hermes first reported a position in Fennec Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Federated Hermes's Fennec Pharmaceuticals position peaked at $27.3K in Q3 2025.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.